Latest
The Future of Esophageal Cancer: Clinical Trials at Wilmot Attempt to Improve Treatments
Researchers at Wilmot Cancer Institute are working to improve treatment for esophageal cancer, a disease that affects 17,000 Americans each year. Often diagnosed after the cancer has spread, the ...
From AML to Ph.D.: How Wilmot helped one patient diagnosed with leukemia
Ege Ozen was working toward his Ph.D. in Political Science when he was diagnosed with acute myeloid leukemia (AML). His oncology team at Wilmot and his wife have helped him through, and he achieved ...
Four things to know about prostate cancer
Prostate cancer is the most common cancer among men in the U.S. Each year, approximately 161,000 men in the U.S. are diagnosed with this type of cancer, including approximately 630 in Monroe County ...
Lymphoma: Targeting treatment for special populations
Patrick Reagan, M.D., is working with Wilmot's Geriatric Oncology team, to develop a targeted approach for treating older adults with diffuse large B-cell lymphoma.
Lymphoma: Looking for Clues in the Immune System
Wilmot researchers are studying the non-cancer cells in a tumor — known as the tumor microenvironment — to learn more about the important role they play in the course of lymphoma.
Sun protection is crucial during, after treatment
Chemotherapy and radiation can increase your sensitivity to the sun, putting you at risk for burns. Even if you’re not sunbathing, it’s important to take precautions any time you’ll be outside.
Following Family History
Wilmot's new Hereditary Cancer Screening and Risk Reduction Clinic supports patients with inherited cancer syndromes and strong family histories of cancer.
Strategies for eating safely at summer picnics
Summer picnics and barbecues are a great time for family and friends but if your immune system is weakened by cancer treatment, these events can also be fraught with food-safety challenges. That ...
Finding Hope and Time
A complex, innovative surgical procedure offers a new option for those facing metastatic colorectal cancer.
Gene Study Points Researchers toward New Pathway for Leukemia
Leukemia is one of the hardest cancers to treat, but scientists have discovered a new, targetable pathway in one of the worst subtypes of the disease.